Study Notes: Hallucinations, Anxiety, and Mood Disorders

Hallucinations, Illusions, Delusions

• Hallucinations: sensory experiences without an external stimulus; they are internal experiences that the person perceives as real.

  • Auditory hallucinations: hearing voices or sounds that are not present.

  • Visual hallucinations: seeing persons or things that are not there.

  • Olfactory hallucinations: smelling odors that are not present.

  • Gustatory (taste) hallucinations: tasting things not related to actual ingestion.

  • Tactile hallucinations: bodily sensations (e.g., insects crawling) with no external cause.

• Illusions: misinterpretations of real stimuli.

  • Example: Desert heat leading to the illusion of an oasis that is not there; heat waves or visual tricks (e.g., sun reflections) can cause misperceptions.

• Delusions: false, fixed beliefs that are not connected to external reality.

  • Common types: delusions of persecution (e.g., CIA monitoring) and delusions of grandeur (e.g., being Cleopatra or a famous movie star).

  • Characteristics: beliefs held despite contrary evidence; not swayed by others’ arguments.

• Practical contrasts and clinical teaching reminders:

  • Hallucinations are sensory experiences with no external source; they are internal experiences affecting perception.

  • Delusions are beliefs about reality that are untrue, fixed, and internally coherent to the person.

  • Illusions are misperceptions of real external stimuli, not created from scratch by the mind.

• Transcript examples and discussion points:

  • A patient claims a fire is in the room and demands escape; response includes presenting reality and ensuring safety (do not reinforce the hallucination).

  • Delusions discussed include a person believing the CIA is monitoring them or that they are a deity or famous figure.

• Key takeaway for care settings:

  • Do not validate or argue with delusions; acknowledge distress and redirect to reality-based cues.

  • Assess safety when hallucinations are command-type or cause distress (e.g., “fire” in the environment).

Anxiety: Spectrum, Disorders, and Concepts

• Anxiety as a normal feature of life vs. anxiety as a disorder:

  • Some level of anxiety is universal; when it becomes chronic or disproportionate, it may be diagnosable.

  • Anxiety disorder features: persistent worry, fear, or avoidance that interferes with functioning.

• Diagnostic levels of anxiety (severity continuum):

  • Mild

  • Moderate

  • Severe

  • Panic

• Signs and symptoms across levels:

  • Physical: increased heart rate, faster breathing, sweating, chest tightness, dizziness, nausea.

  • Emotional/behavioral: agitation, inability to concentrate, irritability, restlessness.

• Trigger vs. free-floating anxiety:

  • Triggered (signal): anxiety with identifiable cue (e.g., test anxiety on Monday).

  • Free-floating: anxiety with no clear trigger; can lead to more severe or panic symptoms and a sense of impending doom.

• Theoretical perspectives mentioned:

  • Psychodynamic (Freud): fixation at early stages (e.g., oral gratification) may contribute to anxiety (not deeply elaborated in notes).

  • Biological: neurotransmitter imbalances, notably reduced GABA activity, contributing to heightened anxiety.

  • GABA (gamma-aminobutyric acid): a key inhibitory neurotransmitter; lower levels are linked to increased anxiety; pharmacologic target for some anti-anxiety meds.

• Pharmacologic treatment themes:

  • Benzodiazepines to acutely reduce anxiety/panic; consider safety and dependence concerns.

  • SSRIs (selective serotonin reuptake inhibitors) as long-term antidepressants that also help anxiety (e.g., citalopram, escitalopram).

  • Other medication classes referenced historically/illustratively: mood stabilizers and anticonvulsants for mood-related issues; not primary anxiolytics.

• Anxiety disorders covered in the notes:

  • Phobias: marked, irrational fears of specific objects or situations.

  • Generalized Anxiety Disorder (GAD): chronic, excessive worry for at least 6 ext{ months} with difficult-to-control symptoms.

  • Obsessive-Compulsive Disorder (OCD): compulsive rituals driven by anxiety relief; performance of rituals reduces distress but increases time/rigidity.

  • Post-Traumatic Stress Disorder (PTSD): anxiety linked to a prior traumatic event; triggers may reactivate symptoms.

• Risk factors for anxiety disorders:

  • Female gender has higher diagnosis rates than male.

  • Acute medical conditions can elevate risk.

  • Substance use (alcohol or drugs) can contribute to or exacerbate anxiety.

• Diagnostic framework and assessment:

  • DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, 5th Edition) provides symptom criteria and thresholds for diagnosis.

  • Clinicians use thorough history, clinical presentation, and potentially screening tools to determine if criteria are met.

  • DSM-5 criteria typically require a constellation of symptoms across domains (thresholds vary by disorder).

• Preventive and coping strategies (prevention-focused section):

  • Teach effective coping strategies to mitigate anxiety symptoms.

  • Early identification of triggers and development of adaptive responses.

• Common screening and assessment tools referenced:

  • PHQ-9 (Patient Health Questionnaire-9) used for depressive symptoms; questions reference the past two weeks.

  • DSM-5 criteria guide formal diagnoses; clinicians rely on history, exam, and sometimes labs.

Mood Disorders: Major Depression and Bipolar Disorder

• Major Depression (unipolar depression):

  • Core features include persistent low mood and anhedonia (loss of pleasure).

  • Associated symptoms: sleep disturbance, appetite change (weight loss or gain), excessive guilt, hopelessness, poor concentration, psychomotor retardation, social withdrawal, and possible suicidal ideation.

  • Functional impact: interfere with ADLs and daily functioning.

  • Psychomotor changes: retardation (slowed movements) or agitation.

  • Isolation often occurs (withdrawal from family, friends, and activities).

• Bipolar Disorder: mood episodes alternating between depressive and manic/hypomanic states.

  • Manic features (during mania): elevated mood, increased energy, decreased need for sleep, pressured or rapid speech, flight of ideas, distractibility, grandiosity, impulsive or risky behaviors (e.g., reckless spending).

  • Mood instability: extreme highs (mania/hypomania) and lows (depression) with potential impairment in judgment and social/occupational functioning.

  • In depressive phases: fatigue, anhedonia, guilt, sleep/appetite changes, slowed thinking, and possible suicidal thoughts.

  • The combination of depressive and manic episodes defines bipolar spectrum disorders.

• Anhedonia and changes in affect:

  • Anhedonia: reduced ability to experience pleasure from activities previously enjoyed.

  • Affect described as flat or labile; dramatic shifts in mood can occur during manic phases.

• Cognitive and functional impacts:

  • Impaired concentration, memory, and decision-making during depressive episodes.

  • In mania, increased goal-directed activity, distractibility, and rapid or disorganized thoughts can impair functioning.

• Thoughts of suicide and safety concerns:

  • Suicidal ideation can occur in major depression and during severe depressive or mixed states.

  • Risk assessment and safety planning are critical in nursing care.

• Diagnostic and assessment tools mentioned:

  • PHQ-9 used for depressive symptoms; questions cover the past two weeks to establish presence and severity of depression.

  • DSM-5 criteria used to establish diagnosis, including assessment of manic/hypomanic symptoms when bipolar spectrum is suspected.

• Possible etiologies and risk factors:

  • Loss, unresolved anger, or altered perception of events can contribute to depressive or bipolar presentations.

  • Biological factors: imbalances in neurotransmitters such as serotonin and epinephrine may play a role.

  • Genetic predisposition: family history can increase risk.

• Treatment approaches for mood disorders:

  • Antidepressants: SSRIs (e.g., citalopram, escitalopram) are commonly used.

  • Mood stabilizers: lithium is a classic mood stabilizer for bipolar disorder; anticonvulsants (e.g., valproate [Depakote], lamotrigine [Lamictal], levetiracetam [Keppra]) can be used as mood stabilizers or adjuncts.

  • Atypical therapies: may include antipsychotics or other agents depending on presentation.

  • Electroconvulsive Therapy (ECT): used for major depression that is severe or resistant to medications; involves inducing a controlled seizure; requires pre-assessment (e.g., labs, chest X-ray) to determine candidacy.

  • Side effects and post-procedure considerations: transient confusion and muscle soreness after ECT; temporary cognitive effects can occur.

  • Mood stabilization strategies in clinical care: ensure adherence, monitor for mania/depression shifts, and adjust medications accordingly.

• Treatment goals and monitoring:

  • Stabilize mood swings to improve ADLs and functioning.

  • Monitor response to medications and adjust as needed to minimize side effects and avoid misuse/dependence.

  • In bipolar mania: address impulsivity and risk-taking behaviors; ensure safety for patient and others.

Treatments, Therapies, and Interventions

• Psychopharmacology overview (as discussed):

  • Benzodiazepines: short-term relief of acute anxiety or panic; use with caution due to dependence risk.

  • SSRIs: long-term management of anxiety and depressive symptoms (e.g., citalopram, escitalopram).

  • Mood stabilizers/anticonvulsants for mood disorders and bipolar spectrum (e.g., lithium, Depakote, Lamictal, Keppra).

• Non-pharmacologic therapies:

  • Systematic desensitization: gradual exposure to feared stimuli to reduce phobic response.

  • Psychotherapy (behavioral management and cognitive-behavioral approaches): address thought patterns and behaviors; requires informed consent for treatment.

  • Mood therapy and hypnosis (relaxation, imagery, breathing techniques) to reduce anxiety and improve coping.

  • Biofeedback: use of machines to monitor physiologic signals (heart rate, respiration, blood pressure) so patients learn to regulate these responses.

  • Breathing techniques and relaxation as ongoing self-management tools.

  • Observation and self-talk strategies: positive self-talk to restructure anxious thinking.

• Nursing interventions and safety planning:

  • Identify triggers and escalate safety measures as needed.

  • Monitor for suicidal ideation and document changes in behavior, both improvements and deteriorations.

  • Provide supportive, non-judgmental communication; use objective statements (e.g., "I see you brushed your hair today"), not evaluative praise or criticism.

  • In acute panic or manic states, prioritize safety and consider separating the patient from a group setting; implement one-on-one calming strategies in a quiet environment.

  • Do not leave a patient alone during severe panic or mania due to safety concerns; ensure a safe environment and supervising presence.

• Patient observation and documentation examples:

  • Document triggers and responses to interventions.

  • Record attempts at coping strategies (e.g., breathing exercises) and their effects on symptoms.

  • Note adherence, perceived relief, and functional improvements (e.g., improved sleep, appetite, or ability to perform ADLs).

  • Include both positive progress (e.g., patient engages in breakfast) and ongoing concerns (e.g., persistent anxiety or agitation).

• Complications and course: major depression vs. bipolar course considerations:

  • Major depression can impair ADLs and social functioning; mood may remain low with intermittent improvement.

  • Bipolar disorder is characterized by alternating episodes of depression and mania/hypomania with potential risk-taking, grandiosity, and impaired judgment during mania.

  • Psychomotor changes, sleep disturbances, appetite changes, guilt, hopelessness, and suicidal ideation are common across mood disorders, but presentation varies with episode type.

Diagnostics, Criteria, and Real-World Relevance

• DSM-5 in practice:

  • Provides diagnostic criteria with symptom thresholds; clinicians apply these criteria based on clinical interviews, history, and sometimes screening tools.

  • Not designed for non-clinician use; specialists rely on DSM-5 criteria to justify diagnoses and treatment planning.

• PHQ-9 and mood assessment:

  • The PHQ-9 is a brief tool used to screen for depressive symptoms over the past two weeks; responses guide further evaluation and treatment decisions.

• Real-world relevance and connections:

  • Diagnostic criteria inform treatment choices (e.g., SSRIs for depressive/anxiety symptoms, mood stabilizers for bipolar mood episodes).

  • Understanding hallucinations, delusions, and illusions helps differentiate psychotic disorders from mood or anxiety disorders and guides safety planning and treatment prioritization.

  • Ethical considerations include obtaining informed consent for psychotherapy, respecting patient autonomy, and balancing safety with individual rights (e.g., during acutely agitated or manic states).

  • The educator notes emphasize the clinical reality of safety planning, non-judgmental communication, and careful observation of changes in mood, behavior, and function.

Connections to Foundational Principles and Real-World Applications

• Core concepts connected to biology and psychology:

  • Neurotransmitter balance (e.g., GABA, serotonin, epinephrine) influences anxiety and mood.

  • Cognitive-behavioral frameworks address how thoughts influence emotions and behaviors.

  • Psychoeducation and coping skills empower patients to manage symptoms and reduce relapse risk.

• Ethical and practical implications:

  • Consent and patient autonomy in therapeutic interventions (e.g., psychotherapy approaches, desensitization).

  • Safety as a primary concern in acute anxiety, mania, or suicidality; environmental controls and monitoring are essential.

  • Observational reporting by nurses and clinicians helps tailor interventions without bias or overgeneralization.

• Numerical references and timing to remember:

  • Generalized anxiety disorder requires excessive worry for at least 6 ext{ months}.

  • PHQ-9 evaluates symptoms over the past two weeks.

  • ECT is a procedure with temporary post-therapy confusion and muscle soreness; pre-procedure tests guide candidacy.

Quick Reference: Key Terms and Examples

• Hallucination: hearing voices, seeing people, smelling odors, tasting flavors, or feeling sensations without external stimuli.

• Illusion: misperception of real external stimuli (e.g., heat haze mistaken for water).

• Delusion: fixed false belief not shared by others or supported by reality (e.g., CIA monitoring, grandiosity).

• Anxiety spectrum: mild to panic; triggers vs. free-floating; physiological and cognitive symptoms.

• Phobia: persistent, irrational fear of a specific object/situation.

• GAD: chronic, excessive worry for at least 6 ext{ months}, difficult to control.

• OCD: obsessions with compulsions performed to relieve anxiety.

• PTSD: anxiety triggered by a perceived threat or trauma, persisting after the event.

• Major Depression: persistent low mood, anhedonia, sleep/appetite changes, cognitive symptoms, potential suicidality.

• Bipolar Disorder: episodes of depression and mania/hypomania with significant mood and behavioral changes.

• Treatments discussed: SSRIs (e.g., citalopram, escitalopram), benzodiazepines, mood stabilizers (lithium, Depakote, Lamictal, Keppra), ECT, psychotherapy, desensitization, biofeedback, breathing/relaxation, and supportive nursing interventions.

• Safety priorities in care: monitor for suicidality, maintain a safe environment, avoid reinforcing delusional content, and provide calm, non-judgmental support.